Physicians' Academy for Cardiovascular Education

The mechanism of SGLT2 inhibition in glucose control

July 24, 2015


A mechanism of action animation of SGLT2-inhibition, a diabetes therapy that directly targets glucose by reducing renal glucose reabsorption, independently of beta cell function and insulin resistance.

Provided as an educational service by Boehringer Ingelheim - Lilly